AI-Enhanced Predictive Analytics to Optimize Tele-Oncology Implementation in Rural Settings: Scoping Review
Clinical Snapshot
PICO Framework
| P — Population | Rural and underserved populations requiring oncology care, including patients and healthcare providers in rural settings across high-resource countries |
| I — Intervention | AI-enhanced predictive analytics applied to tele-oncology implementation (including machine learning models for modality preference prediction, AI-generated health literacy content, remote monitoring platforms, and proof-of-concept validation tools) |
| C — Comparator | No explicit comparator; the review maps the evidence landscape rather than comparing interventions head-to-head — standard tele-oncology without AI enhancement is the implicit reference |
| O — Outcomes | Implementation outcomes (feasibility, adoption, fidelity, sustainability), patient engagement, telehealth modality preference prediction accuracy, health literacy engagement, and identification of implementation barriers across patient, provider, organisational, and system levels |
Bottom Line
This scoping review maps a critically important but severely underdeveloped evidence base at the intersection of AI-enhanced predictive analytics, tele-oncology, and rural health equity. From 330 screened records, only four studies met inclusion criteria — a yield that itself signals the structural immaturity of this field. The included studies demonstrate proof-of-concept feasibility (86.2% accuracy in predicting telehealth modality preferences; 2.52-fold greater engagement with AI-generated health literacy content in disadvantaged populations) but provide no comparative effectiveness data, no health economic analyses, and no algorithmic bias assessments. A critical finding is the 'organisational threshold effect': AI innovations appear unable to overcome structural resource constraints in rural facilities, meaning technological sophistication without adequate provider capacity and infrastructure is insufficient. The evidence base is geographically concentrated in high-resource settings (US, Greece, Singapore), with no representation from Australia or comparable rural health systems. Current evidence cannot support definitive practice recommendations. For Australian oncology clinicians and health system planners, this review should inform a research agenda prioritising equity-centred AI validation in authentic rural contexts, rather than premature adoption of AI-enhanced tele-oncology tools whose effectiveness and safety in underserved populations remain undemonstrated.
Key Findings
P Value: Male vs female video selection: P=.004; urban vs rural video selection: P<.001
Effect Size: Telehealth modality preference predicted with 86.2% accuracy; male patients had 66% increased odds of video selection versus female patients; urban residents had 101% increased odds of video selection versus rural residents; disadvantaged populations engaged with AI-generated health literacy content 2.52-fold more frequently than non-disadvantaged counterparts
Primary Outcome: Mapping of evidence on AI-enhanced predictive analytics in rural tele-oncology implementation; three themes identified: (1) current tele-oncology implementation landscape in rural/underserved settings, (2) potential AI applications addressing implementation challenges, (3) implementation considerations for AI systems themselves
Nnt Or Sensitivity: Not applicable for scoping review; no NNT, sensitivity, specificity, or hazard ratio data reported; the 86.2% prediction accuracy is an individual study finding without confidence interval or external validation data
Confidence Interval: Not reported for any finding in the abstract
Clinical Application
Current evidence is insufficient to support implementation of AI-enhanced predictive analytics in rural tele-oncology at scale. The finding that organisational threshold effects limit AI effectiveness under resource constraints is particularly important: health systems must ensure adequate provider capacity and infrastructure before deploying algorithmic tools. Implementation feasibility is context-dependent and cannot be generalised from four heterogeneous studies. No Australian studies were included in this review. Australia's rural and remote oncology context — characterised by vast geographic distances, the Royal Flying Doctor Service, state-based cancer networks, and significant Indigenous health disparities — is not represented in the evidence base. The Australian Digital Health Agency's national telehealth framework and the RACGP's rural health guidelines provide relevant implementation infrastructure, but AI-enhanced predictive analytics for rural tele-oncology is not currently addressed in TGA regulatory guidance or PBS funding frameworks. Cancer Australia's rural cancer care priorities align with the equity concerns raised in this review. Australian clinicians and health systems should treat this review as hypothesis-generating rather than practice-guiding. The MBS telehealth item numbers expanded post-COVID-19 provide a policy context for tele-oncology, but AI-specific implementation evidence from Australian rural settings is absent and urgently needed. Rural and underserved cancer patients requiring oncology care via telehealth; oncology providers and health systems considering AI-enhanced tele-oncology implementation in resource-constrained settings. Most directly applicable to US rural oncology contexts given the geographic distribution of included studies.
Abstract
BACKGROUND: Tele-oncology addresses geographic barriers to cancer care, but implementation challenges persist in rural settings. AI-enhanced predictive analytics offer opportunities for optimizing deployment through personalized, data-driven strategies; however, evidence in rural tele-oncology contexts remains limited, and critical equity considerations remain underexamined. OBJECTIVE: This scoping review aimed to map evidence on AI-enhanced predictive analytics in tele-oncology implementation, with particular attention to rural and underserved populations, to identify research gaps and inform implementation science priorities. METHODS: We searched 5 databases (PubMed, Embase, CINAHL, Web of Science, and IEEE Xplore) using 4 concept domains (tele-oncology, rural implementation barriers, AI or predictive analytics, implementation science) from January 2015 through November 2025. Two independent reviewers screened 330 unique records (title or abstract; Cohen κ=0.78), with the principal investigator resolving conflicts. Of 138 full-text reviews (κ=0.82), 4 studies met inclusion criteria. Data extraction captured study characteristics, AI applications, implementation factors, and outcomes. We used narrative thematic analysis to map findings into three themes: (1) the current tele-oncology implementation landscape in rural and underserved settings, (2) potential AI applications addressing implementation challenges, and (3) implementation considerations for AI systems themselves. RESULTS: Four included studies (1 pilot feasibility study, 1 proof-of-concept validation study, 1 cross-sectional predictive study, and 1 platform development study; published 2019-2025) demonstrated limited evidence at the intersection of AI, tele-oncology, and rural health equity. Patient characteristics predicted telehealth modality preferences with 86.2% accuracy, revealing that male patients exhibited 66% increased odds of video selection versus female patients (P=.004), and urban residents showed 101% increased odds compared to rural counterparts (P<.001). Liu et al demonstrated that disadvantaged populations engaged with AI-generated health literacy content 2.52-fold more frequently than nondisadvantaged counterparts. However, all 4 studies documented substantial implementation barriers (patient, provider, organizational, and system levels) persisting despite technological sophistication. Organizational threshold effects, where remote monitoring interventions succeeded with adequate provider capacity but failed under resource constraints-suggest that algorithmic innovations cannot overcome structural limitations in rural facilities. No studies explicitly examined algorithmic bias, cross-population validation, or potential harms in rural contexts. Geographic concentration in high-resource countries (United States n=2, Greece n=1, and Singapore n=1) and limited oncology-specific focus underscore structural gaps in knowledge generation for underserved populations. CONCLUSIONS: Current evidence remains insufficient to support definitive practice recommendations. The observed evidence gap may reflect broader structural inequities in knowledge generation: populations with the greatest implementation challenges appear to remain substantially underrepresented in AI and digital health literature. Future research should prioritize comparative effectiveness studies in authentic rural contexts with implementation science outcomes, equity-centered cross-population validation, specification of translation mechanisms linking AI predictions to implementation strategies, health economic analyses, and mechanistic research on sociotechnical integration factors, ensuring technological innovation reduces rather than perpetuates disparities in cancer care.
References
- 1.Husain, L., Mullins, M., Etingen, B., Zafar, R. M., Siddiqui, M., & Jackson, G. L. (2026). AI-Enhanced predictive analytics to optimize tele-oncology implementation in rural settings: Scoping review. JMIR Cancer. https://doi.org/10.2196/68516
Related Research
Cancer medicine
Applications of Artificial Intelligence in Cancer Diagnosis and Treatment
1 Aug 2026
Acta oncologica (Stockholm, Sweden)
User perceptions of machine learning models as decision support for colorectal cancer multidisciplinary team conferences (AID-SIM-2): a qualitative simulation study.
1 Aug 2026
Journal of breast imaging
Contrast-Enhanced Mammography for Breast Cancer Screening: A Systematic Review and Meta-Analysis
30 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service